Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far.
MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value – Biotech Investments
EQS-News: MorphoSys AG / Key word(s): Mergers & Acquisitions/Disposal MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity